August 27, 2020 QUARTERLY REPORT – 2020 Q2
Posted at 11:48h
in quarterly-reports
QUARTERLY REPORT – 2020 Q2 (PDF)...
August 21, 2020 VACCIBODY FINALIZES PATIENT ENROLMENT IN VB N-01 PHASE I/IIa TRIAL WITH ITS NOVEL VB10.NEO NEOANTIGEN CANCER VACCINE
Posted at 08:02h
in Uncategorized
VACCIBODY FINALIZES PATIENT ENROLMENT IN VB N-01 PHASE I/IIa TRIAL View press release (PDF)...
August 12, 2020 VACCIBODY AND NEKTAR THERAPEUTICS DOSES FIRST PATIENT IN PHASE 1/2A STUDY ARM EVALUATING VB10.NEO IN COMBINATION WITH BEMPEGALDESLEUKIN
Posted at 13:02h
in Uncategorized
First patient dosed in VB N-01 study arm with VB10.NEO plus Bempegaldesleukin (NKTR-214) View press release (PDF)...
July 7, 2020 Minutes from Extraordinary General Meeting in Vaccibody AS
Posted at 08:00h
in Uncategorized
Minutes from Extraordinary General Meeting in Vaccibody AS...
July 2, 2020 Vaccibody doses first patient in Phase II clinical trial of VB10.16 in combination with immune-checkpoint inhibitor in advanced cervical cancer
Posted at 07:57h
in Uncategorized
Vaccibody doses first patient in VB C-02 study with VB10.16 plus atezolizumab (PDF)....
June 29, 2020 NOTICE OF AN EXTRAORDINARY GENERAL MEETING 6 JULY 2020
Posted at 12:00h
in Uncategorized
NOTICE OF AN EXTRAORDINARY GENERAL MEETING 6 JULY 2020 (PDF)...
May 12, 2020 QUARTERLY REPORT – 2020 Q1
Posted at 08:00h
in quarterly-reports
QUARTERLY REPORT – 2020 Q1 (PDF)...
April 23, 2020 Minutes from Annual General Meeting in Vaccibody AS
Posted at 14:04h
in Uncategorized
Minutes from Annual General Meeting in Vaccibody AS...
April 15, 2020 2019 Annual Report and Notice of Annual General Meeting April 22nd, 2020
Posted at 08:00h
in Uncategorized
Invite Notice Report...
April 14, 2020 Invitation to Business Update April 16th 2020
Posted at 09:24h
in Uncategorized
Invitation to Business Update April 16th 2020...